Lily MedTech

Tokyo, Japan Founded: 2016 • Age: 10 yrs
Ultrasound-based diagnostic imaging for breast cancer detection is developed.

About Lily MedTech

Lily MedTech is a Healthcare company based in Tokyo (Japan) founded in 2016. Ultrasound-based diagnostic imaging for breast cancer detection is developed. Lily MedTech has raised $3.31 million across 2 funding rounds from investors including Beyond Next Ventures, Fuyo General Lease and Mitsubishi UFJ Capital. Its chief executive, as recorded, is Shiho Azuma. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Women's Cancer.

Company details

Lily MedTech was established in 2016 as a venture from the University of Tokyo. Diagnostic imaging equipment utilizing ultrasound technology for breast cancer detection is being developed by the company within the medtech sector. Operations are conducted from Tokyo, Japan, where the focus remains on advancing non-invasive diagnostic solutions. Leadership is provided by CEO Shiho Azuma, with emphasis placed on research and equipment innovation.

  • Headquarters Tokyo, Japan
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lilymedtech.com
  • Social Facebook
Operational Areas
Key Metrics

Funding Insights of Lily MedTech

Lily MedTech has successfully raised a total of $3.31M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.31M
  • Total Rounds 2
  • First Round $3.31M

    (Mar 2018)

  • Investors Count 4

All 2 funding rounds of Lily MedTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2018Series A––
Mar 2018$3.31MSeries A––
Valuation history

4 investors in total: 4 institutional.

Investors in Lily MedTech

Lily MedTech has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Beyond Next Ventures, Fuyo General Lease and Mitsubishi UFJ Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital is invested in AI, energy, and various sectors.
mucap.co.jpTokyo, Japan
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
2014beyondnextventures.comTokyo, Japan
Science and technology research funding and event organization in Japan.
jst.go.jp
Leasing and installment sales company
1969fgl.co.jpChiyoda City, Japan
Premium access

Investor details for Lily MedTech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Lily MedTech

3 people are tracked at Lily MedTech (3 in leadership).

NameRoleGroup
Shiho Azuma
CEOLeadership
Takashi Azuma
Director & CTOLeadership
Yohei Kondo
Director COO & CFOLeadership
Premium access

Complete people profiles for Lily MedTech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Lily MedTech

3 dated milestones of Lily MedTech across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lily MedTech is founded.
  2. Funding First funding round of $3.3M.
  3. Funding Latest funding round, Series A,.

Web traffic of Lily MedTech

The website of Lily MedTech (lilymedtech.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▼ 2.1% vs previous month

Similar websites

Websites whose visitors overlap most with Lily MedTech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
kigyoka.com
kigyoka.com
100%
#3,651,139–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lily MedTech

Lily MedTech was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Lily MedTech is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

Shiho Azuma is the CEO of Lily MedTech, as recorded in our data.

Lily MedTech is a funded company, having raised a total of $3.31M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.31M, raised on Mar 2018.

Lily MedTech was established in 2016 as a venture from the University of Tokyo. Diagnostic imaging equipment utilizing ultrasound technology for breast cancer detection is being developed by the company within the medtech sector. Operations are conducted from Tokyo, Japan, where the focus remains on advancing non-invasive diagnostic solutions. Leadership is provided by CEO Shiho Azuma, with emphasis placed on research and equipment innovation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available